Diferencia entre revisiones de «Short bowel syndrome»

Sin resumen de edición
Sin resumen de edición
Línea 173: Línea 173:
*[[D-lactic acidosis]]
*[[D-lactic acidosis]]
*[[Dumping syndrome]]
*[[Dumping syndrome]]
*[[Central Line Associated Blood Stream Infections|CRBSI]]
*[[Wernicke encephalopathy]]
*[[Wernicke encephalopathy]]
*[[Renal stone]]
*[[Renal stone]]

Revisión del 22:07 13 mar 2026

Background

  • Short bowel syndrome (SBS) is a malabsorptive condition resulting from the loss of functional small intestinal length or absorptive capacity, typically defined as < 200 cm of remaining small bowel in adults (normal length 275–850 cm)[1]
  • Results in intestinal failure when the remaining bowel cannot sustain nutritional, fluid, and electrolyte needs without parenteral support
  • Etiologies in adults:
    • Crohn's disease (most common cause requiring repeated resections)
    • Mesenteric ischemia / mesenteric vascular occlusion
    • Radiation enteritis
    • Volvulus
    • Trauma (penetrating abdominal trauma with bowel loss)
    • Surgical complications / adhesive small bowel obstruction requiring resection
    • Malignancy
  • Etiologies in children:
    • Necrotizing enterocolitis (NEC) — most common neonatal cause
    • Intestinal atresia / congenital malformations
    • Midgut volvulus
    • Gastroschisis
  • Anatomy determines clinical consequences:[2]
    • Jejunum-colon anastomosis (colon in continuity): Better prognosis; colon absorbs water, electrolytes, and short-chain fatty acids from bacterial carbohydrate fermentation; at risk for D-lactic acidosis and oxalate kidney stones
    • End-jejunostomy (no colon in continuity): Higher fluid/electrolyte losses; greater dependence on parenteral nutrition; at risk for dehydration and sodium depletion
    • Ileal resection: Loss of vitamin B12 absorption (terminal ileum) and bile salt reabsorption → bile salt diarrhea and fat malabsorption
    • Ileocecal valve loss: Increases bacterial overgrowth and accelerates transit
  • Bowel length thresholds for parenteral nutrition dependence:[1]
    • > 180 cm: Generally no PN needed
    • 90–180 cm: PN usually needed for < 1 year
    • < 90 cm: Prolonged or lifelong PN likely
    • < 60 cm: Almost always requires lifelong PN or transplant consideration
  • Intestinal adaptation occurs over 1–2 years after resection: villous hyperplasia, crypt deepening, bowel dilation → gradual improvement in absorptive capacity

Clinical Features

Chronic / Baseline Symptoms

  • Diarrhea / steatorrhea — high-volume, watery; may be > 2 L/day with end-jejunostomy
  • Malnutrition and weight loss
  • Dehydration and electrolyte derangements (hyponatremia, hypokalemia, hypomagnesemia, hypocalcemia)
  • Fatigue, weakness
  • Abdominal distension, bloating, cramping
  • Peripheral edema (hypoalbuminemia)

Complications Presenting to the ED

  • Severe dehydration / electrolyte crisis:[2]
    • Hyponatremia, hypokalemia, hypomagnesemia (often refractory — Mg must be corrected before K will correct)
    • Metabolic acidosis (bicarbonate losses from high-output stoma/diarrhea) or metabolic alkalosis (dehydration, acid loss from vomiting)
    • Hypocalcemia (from vitamin D malabsorption and hypomagnesemia)
  • Central line complications (most SBS patients have long-term central venous catheters for parenteral nutrition):
    • Catheter-related bloodstream infection (CRBSI): Most common life-threatening complication of PN; presents with fever, chills, rigors temporally related to PN infusion[2]
    • Central line thrombosis / occlusion
    • Catheter malposition, fracture, air embolism
  • D-lactic acidosis: Anion gap metabolic acidosis + encephalopathy (confusion, ataxia, slurred speech) after high-carbohydrate meals; occurs in patients with colon in continuity
  • Small intestinal bacterial overgrowth (SIBO): Bloating, diarrhea worsening, abdominal pain, malodorous gas; may cause fever and elevated WBC
  • Intestinal failure–associated liver disease (IFALD): Jaundice, hepatomegaly, elevated LFTs; related to chronic PN use
  • Cholelithiasis: SBS patients (especially < 180 cm with absent ileocecal valve) have increased risk of calcium bilirubinate gallstones → cholecystitis, choledocholithiasis
  • Oxalate nephrolithiasis / nephropathy: Hyperoxaluria occurs when unabsorbed fatty acids bind calcium, leaving oxalate free for colonic absorption → calcium oxalate kidney stones
  • Metabolic bone disease: Osteoporosis/osteomalacia from vitamin D and calcium malabsorption → pathologic fractures
  • Nutritional deficiency emergencies:
    • Vitamin B12 deficiency: Megaloblastic anemia, subacute combined degeneration of the spinal cord (from terminal ileum loss)
    • Thiamine deficiency: Wernicke encephalopathy
    • Vitamin K deficiency: Coagulopathy
    • Iron deficiency anemia
    • Zinc deficiency: Dermatitis, alopecia, impaired wound healing
  • Bowel obstruction: From adhesions related to prior surgeries

Differential Diagnosis

Evaluation

Workup

  • BMP/CMP: Electrolytes (Na, K, Mg, Ca, Phos — all frequently abnormal), BUN/creatinine (dehydration/renal injury), bicarbonate (acidosis), glucose, liver enzymes, albumin
  • Magnesium level: Often critically low; must be corrected before hypokalemia will respond to potassium replacement
  • CBC: Anemia (B12 deficiency → macrocytic; iron deficiency → microcytic), leukocytosis if infection
  • Lactate: Evaluate for sepsis, mesenteric ischemia; remember standard assay measures only L-lactate (see D-lactic acidosis)
  • Blood cultures (peripheral AND through central line if present): If fever, suspicion for CRBSI — draw paired cultures before antibiotics
  • Coagulation studies: PT/INR (vitamin K deficiency → elevated INR)
  • Urinalysis: Oxalate crystals, infection
  • VBG/ABG: Acid-base status
  • LFTs: Evaluate for IFALD, biliary disease
  • Vitamin levels (if clinically indicated): B12, folate, 25-OH vitamin D, thiamine, zinc — may not be immediately available but should be sent
  • Imaging:
    • Abdominal XR: If concern for obstruction
    • CT abdomen/pelvis: Obstruction, abscess, mesenteric ischemia, cholecystitis
    • Ultrasound: Right upper quadrant for gallbladder/biliary evaluation
    • CXR: If concern for line malposition, pneumothorax, aspiration

Diagnosis

  • SBS itself is a known condition — the ED role is to identify the acute complication bringing the patient in
  • Key diagnostic patterns in SBS patients:
Presentation Likely Complication
Fever + rigors during or after PN infusion CRBSI — draw blood cultures (line and peripheral)
AGMA + normal L-lactate + encephalopathy after carbs D-lactic acidosis — send D-lactate level
Refractory hypokalemia despite IV K replacement Hypomagnesemia — check and replace Mg first
Elevated INR + easy bruising, no anticoagulant use Vitamin K deficiency — give IV vitamin K
Flank pain + hematuria Oxalate nephrolithiasis — CT KUB
Ataxia, confusion, ophthalmoplegia Wernicke encephalopathy — give IV thiamine empirically
Macrocytic anemia + neurologic symptoms B12 deficiency — send B12 level, IM cyanocobalamin
High-output stoma with hypotension, tachycardia Dehydration/electrolyte crisis — aggressive IV resuscitation

Management

Dehydration / Electrolyte Crisis

  • Aggressive IV fluid resuscitation: Normal saline initially; avoid hypotonic fluids (SBS patients often have chronic sodium depletion)
  • Electrolyte repletion:
    • Magnesium FIRST — IV magnesium sulfate 2–4 g over 1–2 hours; hypokalemia and hypocalcemia are often refractory until Mg is corrected[2]
    • Potassium: IV KCl; monitor closely with serial BMPs
    • Calcium: IV calcium gluconate if symptomatic or severe; send vitamin D level
    • Phosphorus: Replete if low (especially if refeeding)
  • Oral rehydration solution (ORS): SBS patients benefit from glucose-sodium ORS (WHO formulation) rather than plain water, which can worsen sodium depletion
  • Monitor urine output — target > 0.5 mL/kg/hr

Catheter-Related Bloodstream Infection

  • Draw blood cultures from the line AND a peripheral site before antibiotics
  • Empiric IV antibiotics: Vancomycin + gram-negative coverage (cefepime or piperacillin-tazobactam); adjust based on cultures[2]
  • Do NOT routinely remove the line unless: hemodynamic instability/septic shock, tunnel infection, persistent bacteremia > 72 hours on appropriate antibiotics, or fungemia
  • These patients have limited venous access — line preservation is critical when possible; consult the patient's PN team or vascular access specialist

D-Lactic Acidosis

  • NPO / fasting (eliminate carbohydrate substrate)
  • IV sodium bicarbonate for significant acidosis
  • IV thiamine 100 mg empirically
  • Enteral antibiotics (metronidazole, oral vancomycin)
  • See D-lactic acidosis for full management

Nutritional Deficiency Emergencies

  • Vitamin K deficiency (elevated INR): IV vitamin K 10 mg; FFP or PCC if actively bleeding
  • Wernicke encephalopathy: IV thiamine 500 mg TID × 3 days (high-dose protocol)
  • B12 deficiency: IM cyanocobalamin 1,000 mcg
  • Iron deficiency: IV iron infusion (in consultation with GI/hematology)

General Principles

  • Contact the patient's GI/nutrition/intestinal rehabilitation team early — these patients often have complex management plans and established relationships with specialists
  • Do not discontinue or modify parenteral nutrition without specialist guidance
  • Loperamide / codeine phosphate: May be used to reduce stoma/stool output (often part of home regimen)
  • PPI / H2 blocker: Reduce gastric hypersecretion that occurs in SBS (especially in the first 6–12 months)

Disposition

  • Admit:
    • Suspected CRBSI / sepsis
    • Severe dehydration requiring IV repletion > 24 hours
    • Significant electrolyte derangements (symptomatic hyponatremia, hypokalemia, hypomagnesemia)
    • D-lactic acidosis with encephalopathy
    • Bowel obstruction
    • Symptomatic nephrolithiasis requiring urologic intervention
    • Severe nutritional deficiency emergencies (Wernicke, severe B12 deficiency with neurologic involvement)
  • ICU admission:
    • Septic shock from CRBSI
    • Severe metabolic derangement with hemodynamic instability
    • Altered mental status (D-lactic acidosis, Wernicke, severe electrolyte abnormality)
  • Discharge with close follow-up:
    • Mild dehydration responding to oral/IV rehydration in the ED
    • Mild electrolyte abnormalities corrected in the ED with reliable outpatient follow-up
    • Ensure the patient's GI/nutrition team is contacted and aware of the ED visit
    • Provide ORS instructions and dietary counseling

See Also

External Links

References

  1. 1.0 1.1 Short Bowel Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. PMID 30860742.
  2. 2.0 2.1 2.2 2.3 2.4 Bering J, DiBaise JK. Short bowel syndrome: complications and management. Nutr Clin Pract. 2023;38(S1):S46-S58. PMID 37115034.